Research and development expense was $15.5 million for the third quarter of 2024, as compared to $7.6 million for the prior year period. The increase in research and development expense was primarily ...

Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

Korro Bio, Inc. (NASDAQ:KRRO), a biotechnology company specializing in RNA editing, is making significant strides in the development of genetic medicines ...

While it’s not shocking that sound, vibration, and frequency have the potential to heal given the ... those new to sound bath ...

Music therapy is a type of therapy that supports mental health through the playing of musical instruments, listening to music, writing music, singing, dancing, or talking about music. It has also been ...

Low-frequency hearing loss is a relatively rare condition in which a person has a decreased ability or inability to hear deeper or low-pitched sounds. These occur in the frequency of 2,000 hertz (Hz) ...

LOS ANGELES--(BUSINESS WIRE)--Terray Therapeutics, a biotechnology company improving human health by transforming the speed, cost, and success rate of small molecule drug development using ...

The reverse stock split was approved by Kintara's stockholders at Kintara's special meeting of stockholders held on October 4, 2024, to be effected in the Board's discretion of not less than 1-for ...

SAN JOSE, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the ...

Viking Therapeutics has two exciting pipeline candidates. The biotech could deliver excellent returns in the next five years if these programs perform well. There are also some risks to consider ...